the cost-effectiveness of clinical pharmacist intervention in reducing the use of tobramycin and in the pharmacokinetic monitoring of aminoglycoside therapy to prevent serious nephrotoxicity were evaluated .
C0040341
tobramycin
C0002556
aminoglycoside